Seattle Genetics Cash on Hand 2006-2019 | SGEN

Seattle Genetics cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Seattle Genetics cash on hand for the quarter ending March 31, 2019 was $0.418B, a 4.6% increase year-over-year.
  • Seattle Genetics cash on hand for 2018 was $0.411B, a 0.6% decline from 2017.
  • Seattle Genetics cash on hand for 2017 was $0.413B, a 29.85% decline from 2016.
  • Seattle Genetics cash on hand for 2016 was $0.589B, a 9.34% decline from 2015.
Seattle Genetics Annual Cash on Hand
(Millions of US $)
2018 $411
2017 $413
2016 $589
2015 $650
2014 $313
2013 $374
2012 $364
2011 $331
2010 $282
2009 $261
2008 $95
2007 $111
2006 $83
2005 $42
Seattle Genetics Quarterly Cash on Hand
(Millions of US $)
Q1 2019 $418
Q4 2018 $411
Q3 2018 $463
Q2 2018 $448
Q1 2018 $400
Q4 2017 $413
Q3 2017 $450
Q2 2017 $452
Q1 2017 $506
Q4 2016 $589
Q3 2016 $592
Q2 2016 $609
Q1 2016 $609
Q4 2015 $650
Q3 2015 $736
Q2 2015 $250
Q1 2015 $296
Q4 2014 $313
Q3 2014 $340
Q2 2014 $349
Q1 2014 $355
Q4 2013 $374
Q3 2013 $374
Q2 2013 $338
Q1 2013 $344
Q4 2012 $364
Q3 2012 $314
Q2 2012 $330
Q1 2012 $309
Q4 2011 $331
Q3 2011 $362
Q2 2011 $411
Q1 2011 $443
Q4 2010 $282
Q3 2010 $303
Q2 2010 $313
Q1 2010 $318
Q4 2009 $261
Q3 2009 $266
Q2 2009 $141
Q1 2009 $132
Q4 2008 $95
Q3 2008 $105
Q2 2008 $114
Q1 2008 $167
Q4 2007 $111
Q3 2007 $92
Q2 2007 $94
Q1 2007 $109
Q4 2006 $83
Q3 2006 $87
Q2 2006 $97
Q1 2006 $36
Q4 2005 $42
Q3 2005 $41
Q2 2005 $44
Q1 2005 $44
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.153B $0.655B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $104.470B 11.81
Gilead Sciences (GILD) United States $85.278B 10.35
Celgene (CELG) United States $67.169B 11.38
Illumina (ILMN) United States $45.930B 53.23
Biogen (BIIB) United States $44.025B 8.36
Vertex Pharmaceuticals (VRTX) United States $43.994B 53.18
Regeneron Pharmaceuticals (REGN) United States $34.155B 16.05
Alexion Pharmaceuticals (ALXN) United States $28.512B 16.14
Incyte (INCY) United States $17.530B 71.09
BioMarin Pharmaceutical (BMRN) United States $15.950B 0.00
Exact Sciences (EXAS) United States $12.511B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.999B 47.71
Sarepta Therapeutics (SRPT) United States $8.961B 0.00
QIAGEN (QGEN) Netherlands $8.614B 28.30
Bio-Techne Corp (TECH) United States $7.491B 51.11
Alnylam Pharmaceuticals (ALNY) United States $7.344B 0.00
Moderna (MRNA) United States $7.182B 0.00
Bluebird Bio (BLUE) United States $6.772B 0.00
Guardant Health (GH) United States $6.708B 0.00
Exelixis (EXEL) United States $6.144B 15.66
Galapagos (GLPG) Belgium $6.114B 0.00
Array BioPharma (ARRY) United States $6.007B 0.00
BeiGene (BGNE) Cayman Islands $5.905B 0.00
Amarin (AMRN) Ireland $5.693B 0.00
Ascendis Pharma (ASND) Denmark $5.434B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.420B 0.00
Spark Therapeutics (ONCE) United States $4.238B 0.00
Blueprint Medicines (BPMC) United States $4.137B 0.00
Alkermes (ALKS) Ireland $3.758B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.743B 0.00
China Biologic Products (CBPO) China $3.582B 22.75
Allogene Therapeutics (ALLO) United States $3.440B 0.00
Global Blood Therapeutics (GBT) United States $3.380B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.327B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.286B 0.00
Repligen (RGEN) United States $3.252B 81.01
Immunomedics (IMMU) United States $2.835B 0.00
Amicus Therapeutics (FOLD) United States $2.807B 0.00
Mirati Therapeutics (MRTX) United States $2.766B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.745B 0.00
Arena Pharmaceuticals (ARNA) United States $2.648B 5.38
Reata Pharmaceuticals (RETA) United States $2.632B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.616B 0.00
Medicines (MDCO) United States $2.578B 0.00
UniQure (QURE) Netherlands $2.381B 0.00
MyoKardia (MYOK) United States $2.295B 0.00
Halozyme Therapeutics (HALO) United States $2.242B 0.00
Ligand Pharmaceuticals (LGND) United States $2.230B 18.47
Emergent Biosolutions (EBS) United States $2.224B 19.32
Acceleron Pharma (XLRN) United States $2.216B 0.00
Lion Biotechnologies (IOVA) United States $2.131B 0.00
Insmed (INSM) United States $2.045B 0.00
NeoGenomics (NEO) United States $2.029B 132.81
AnaptysBio (ANAB) United States $2.019B 0.00
Genomic Health (GHDX) United States $2.005B 42.58
Denali Therapeutics (DNLI) United States $1.979B 0.00
Akcea Therapeutics (AKCA) United States $1.967B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.958B 0.00
Allakos (ALLK) United States $1.913B 0.00
Myriad Genetics (MYGN) United States $1.797B 17.88
Audentes Therapeutics (BOLD) United States $1.687B 0.00
REGENXBIO (RGNX) United States $1.672B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.659B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.598B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.529B 0.00
Innoviva (INVA) United States $1.469B 4.06
Coherus BioSciences (CHRS) United States $1.412B 0.00
Cambrex (CBM) United States $1.402B 17.73
Gossamer Bio (GOSS) United States $1.355B 0.00
Rubius Therapeutics (RUBY) United States $1.346B 0.00
Alector (ALEC) United States $1.343B 0.00
Aimmune Therapeutics (AIMT) United States $1.266B 0.00
Fate Therapeutics (FATE) United States $1.237B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.209B 0.00
Apellis Pharmaceuticals (APLS) United States $1.208B 0.00
Epizyme (EPZM) United States $1.174B 0.00
Sangamo Therapeutics (SGMO) United States $1.121B 0.00
Eidos Therapeutics (EIDX) United States $1.092B 0.00
Atara Biotherapeutics (ATRA) United States $1.075B 0.00
Editas Medicine (EDIT) United States $1.069B 0.00
Codexis (CDXS) United States $1.045B 0.00
RA PHARMCTL INC (RARX) United States $1.001B 0.00
NGM Biopharmaceuticals (NGM) United States $0.987B 0.00
Athenex (ATNX) United States $0.939B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.924B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.912B 0.00
InflaRx (IFRX) Germany $0.912B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.904B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.895B 0.00
Clovis Oncology (CLVS) United States $0.887B 0.00
Myovant Sciences (MYOV) United Kingdom $0.880B 0.00
WAVE Life Sciences (WVE) Singapore $0.871B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.862B 40.70
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.857B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.854B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.853B 0.00
G1 THERAPEUTICS (GTHX) United States $0.848B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.846B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.843B 0.00
ANI Pharmaceuticals (ANIP) United States $0.825B 14.63
Axsome Therapeutics (AXSM) United States $0.824B 0.00
MeiraGTx Holdings (MGTX) United States $0.812B 0.00
Retrophin (RTRX) United States $0.779B 0.00
Intra-Cellular Therapies (ITCI) United States $0.742B 0.00
Twist Bioscience (TWST) United States $0.729B 0.00
Principia Biopharma (PRNB) United States $0.721B 0.00
Cara Therapeutics (CARA) United States $0.718B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.715B 0.00
Cellectis (CLLS) France $0.715B 0.00
CORTEXYME INC (CRTX) United States $0.712B 0.00
Arvinas (ARVN) United States $0.710B 0.00
Vericel (VCEL) United States $0.692B 0.00
Precision BioSciences (DTIL) United States $0.691B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Intellia Therapeutics (NTLA) United States $0.679B 0.00
Zealand Pharma (ZEAL) Denmark $0.664B 7.76
Kura Oncology (KURA) United States $0.654B 0.00
Stemline Therapeutics (STML) United States $0.654B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.629B 0.00
Viking Therapeutics (VKTX) United States $0.615B 0.00
Puma Biotechnology (PBYI) United States $0.597B 0.00
Adverum Biotechnologies (ADVM) United States $0.585B 0.00
Cytokineticsorporated (CYTK) United States $0.580B 0.00
Heska (HSKA) United States $0.580B 59.37
ObsEva SA (OBSV) Switzerland $0.574B 0.00
Magenta Therapeutics (MGTA) United States $0.571B 0.00
Zymeworks (ZYME) Canada $0.566B 0.00
DBV Technologies (DBVT) France $0.550B 0.00
Anika Therapeutics (ANIK) United States $0.541B 18.49
Kaleido Biosciences (KLDO) $0.524B 0.00
Revance Therapeutics (RVNC) United States $0.511B 0.00
Scholar Rock Holding (SRRK) United States $0.510B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
CytomX Therapeutics (CTMX) United States $0.502B 0.00
Synthorx (THOR) United States $0.499B 0.00
MediciNova (MNOV) United States $0.494B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.489B 0.00
Acorda Therapeutics (ACOR) United States $0.489B 8.61
Mesoblast (MESO) Australia $0.478B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.477B 0.00
Replimune (REPL) United States $0.471B 0.00
MILESTONE PHARM (MIST) Canada $0.470B 0.00
Krystal Biotech (KRYS) United States $0.469B 0.00
NEXTCURE INC (NXTC) United States $0.437B 0.00
Sorrento Therapeutics (SRNE) United States $0.429B 0.00
Cyclerion Therapeutics (CYCN) United States $0.415B 0.00
Albireo Pharma (ALBO) United States $0.405B 0.00
Arcus Biosciences (RCUS) United States $0.399B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.394B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.384B 0.00
Agenus (AGEN) United States $0.384B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 0.00
Prothena (PRTA) Ireland $0.378B 0.00
AVROBIO (AVRO) United States $0.376B 0.00
Dynavax Technologies (DVAX) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.374B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
LogicBio Therapeutics (LOGC) United States $0.365B 0.00
UNITY Biotechnology (UBX) $0.363B 0.00
PDL BioPharma (PDLI) United States $0.357B 8.46
Biofrontera AG Sponsored ADR (BFRA) Germany $0.357B 0.00
Kodiak Sciences (KOD) United States $0.352B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.346B 0.00
AC Immune SA (ACIU) Switzerland $0.340B 21.87
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.340B 0.00
Senesco Technologies (ELOX) United States $0.340B 0.00
Kindred Biosciences (KIN) United States $0.332B 0.00
Five Prime Therapeutics (FPRX) United States $0.326B 0.00
AXCELLA HEALTH (AXLA) United States $0.326B 0.00
BeyondSpring (BYSI) United States $0.326B 0.00
XBiotech (XBIT) United States $0.325B 0.00
Kezar Life Sciences (KZR) United States $0.323B 0.00
Abeona Therapeutics (ABEO) United States $0.322B 0.00
Inovio Pharmaceuticals (INO) United States $0.320B 0.00
Cellular Biomedicine (CBMG) United States $0.309B 0.00
Merus (MRUS) Netherlands $0.299B 0.00
Geron (GERN) United States $0.289B 0.00
Kadmon Holdings (KDMN) United States $0.281B 0.00
ResTORbio (TORC) United States $0.273B 0.00
Constellation Pharmaceuticals (CNST) United States $0.272B 0.00
Athersys (ATHX) United States $0.270B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.260B 0.00
Protagonist Therapeutics (PTGX) United States $0.259B 0.00
PHASEBIO PHARMA (PHAS) United States $0.258B 0.00
Aduro Biotech (ADRO) United States $0.256B 0.00
ChromaDex (CDXC) United States $0.255B 0.00
Enochian BioSciences (ENOB) United States $0.250B 0.00
Evelo Biosciences (EVLO) United States $0.245B 0.00
Celcuity (CELC) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.238B 0.00
Mersana Therapeutics (MRSN) United States $0.236B 0.00
Urovant Sciences (UROV) United States $0.231B 0.00
Kamada (KMDA) Israel $0.229B 8.88
Syros Pharmaceuticals (SYRS) United States $0.222B 0.00
OvaScience (MLND) United States $0.221B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.220B 0.00
MannKind (MNKD) United States $0.220B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.217B 0.00
Arsanis (XFOR) United States $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.213B 0.00
Cerecor (CERC) United States $0.213B 0.00
Avid Bioservices (CDMO) United States $0.213B 0.00
Synlogic (SYBX) United States $0.208B 0.00
Chiasma (CHMA) United States $0.206B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.205B 0.00
Kala Pharmaceuticals (KALA) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
VBI Vaccines (VBIV) United States $0.199B 0.00
HOOKIPA PHARMA (HOOK) United States $0.198B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.197B 0.00
Solid Biosciences (SLDB) United States $0.195B 0.00
Celyad SA (CYAD) Belgium $0.193B 0.00
Affimed (AFMD) Germany $0.193B 0.00
Neothetics (EVFM) United States $0.191B 0.00
Liquidia Technologies (LQDA) United States $0.177B 0.00
Intec Pharma (NTEC) Israel $0.175B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.174B 0.00
Cue Biopharma (CUE) United States $0.173B 0.00
Compugen (CGEN) Israel $0.171B 0.00
APPLIED THERAPT (APLT) United States $0.171B 0.00
BioXcel Therapeutics (BTAI) United States $0.170B 0.00
XOMA (XOMA) United States $0.166B 0.00
Axovant Sciences (AXGT) United Kingdom $0.164B 0.00
Seres Therapeutics (MCRB) United States $0.163B 0.00
Anavex Life Sciences (AVXL) United States $0.162B 0.00
Menlo Therapeutics (MNLO) United States $0.161B 0.00
TREVI THERAPTCS (TRVI) United States $0.160B 0.00
Strongbridge Biopharma (SBBP) United States $0.159B 9.19
Checkpoint Therapeutics (CKPT) United States $0.157B 0.00
SESEN BIO, INC (SESN) United States $0.156B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Eton Pharmaceuticals (ETON) United States $0.147B 0.00
Novavax (NVAX) United States $0.144B 0.00
Provention Bio (PRVB) United States $0.142B 0.00
Mustang Bio (MBIO) United States $0.138B 0.00
OSMOTICA PHARM (OSMT) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.127B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.118B 0.00
Trevena (TRVN) United States $0.113B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Aptinyx (APTX) United States $0.112B 0.00
INmune Bio (INMB) United States $0.111B 0.00
TOCAGEN INC (TOCA) United States $0.109B 0.00
Dyadic (DYAI) United States $0.109B 0.00
Arbutus Biopharma (ABUS) Canada $0.109B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.108B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.107B 0.00
Equillium (EQ) United States $0.105B 0.00
Selecta Biosciences (SELB) United States $0.105B 0.00
NantKwest (NK) United States $0.105B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Unum Therapeutics (UMRX) United States $0.099B 0.00
Verastem (VSTM) United States $0.098B 0.00
Pluristem Therapeutics (PSTI) Israel $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Allena Pharmaceuticals (ALNA) United States $0.094B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.092B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Signal Genetics (MGEN) United States $0.086B 0.00
Cohbar (CWBR) United States $0.084B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.083B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.070B 0.00
Alcobra (ARCT) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
Sunesis Pharmaceuticals (SNSS) United States $0.068B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
ScPharmaceuticals (SCPH) United States $0.066B 0.00
OVID THERAPEUTC (OVID) United States $0.066B 0.00
Eyenovia (EYEN) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Apricus Biosciences (SEEL) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Ophthotech (ISEE) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.052B 0.00
AEterna Zentaris (AEZS) United States $0.052B 0.00
Cidara Therapeutics (CDTX) United States $0.051B 0.00
Hoth Therapeutics (HOTH) United States $0.050B 0.00
Moleculin Biotech (MBRX) United States $0.050B 0.00
Curis (CRIS) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.044B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.043B 0.00
Celsion (CLSN) United States $0.043B 0.00
VIVUS (VVUS) United States $0.041B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.040B 0.00
Oncolytics Biotech (ONCY) Canada $0.039B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Edge Therapeutics (PDSB) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.032B 0.00
Aytu Bioscience (AYTU) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
Motif Bio Plc (MTFB) United States $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
GENPREX INC (GNPX) United States $0.025B 0.00
Sophiris Bio (SPHS) United States $0.024B 0.00
GTx (GTXI) United States $0.024B 0.00
Adial Pharmaceuticals (ADIL) United States $0.023B 0.00
Bison Capital Acquisition (XYN) China $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Advaxis (ADXS) United States $0.016B 0.00
Histogenics (HSGX) United States $0.016B 0.00
OncoSec Medical (ONCS) United States $0.016B 0.00
Aileron Therapeutics (ALRN) United States $0.016B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Galena Biopharma (SLS) United States $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
IMMURON LTD (IMRN) Australia $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
RestorGenex (DFFN) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Vital Therapies (IMUX) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Alliqua BioMedical (ADYX) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.004B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00